Literature DB >> 7485402

Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.

J Tamaru1, M Hummel, T Marafioti, B Kalvelage, L Leoncini, C Minacci, P Tosi, D Wright, H Stein.   

Abstract

The normal counterpart of the neoplastic B cells occurring in Burkitt's lymphomas (BL) is an issue of controversial debate. To clarify this matter, a semi-nested primer polymerase chain reaction was performed to amplify the VDJ rearrangements of the immunoglobulin heavy chain (VH) gene of DNA extracts from 10 (8 sporadic and 2 endemic) BL cases. The resulting amplificates were sequenced for comparison with known germ line VH segments. The control cases comprised six cases of B cell chronic lymphocytic leukemia and six cases of mantle cell lymphoma known to display naive nonmutated, ie, pre-germinal center VH configurations; and eight cases of follicular center lymphoma known to display mutated VH genes with signs of a still-ongoing mutation reaction, characteristic for germinal center cells and lymphomas that derive therefrom. The results of this approach revealed that both sporadic and endemic BL express mutated VH genes with a mutation frequency considerably lower (4.9% and 5.4%, respectively) than that observed in follicular center lymphoma (11.8%). In addition, after subcloning the amplificates, sequence analysis revealed no signs of ongoing mutations. These results led us to conclude that the derivation of neoplastic B cells in BL is definitely not from naive, nonmutated pre-germinal center B cells. Instead, our findings support the view that BL cells stem either from early centroblasts that are arrested after an initial hypermutation reaction, or from germinal center B cells that have differentiated in terms of surface immunoglobulin profile and mutation pattern but not in terms of morphology and proliferation toward SIgM+ IgD- memory B cells because of the deregulated c-myc gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485402      PMCID: PMC1869537     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  CHILDHOOD LYMPHOSARCOMA IN ST. LOUIS, MISSOURI, CLINICALLY AND HISTOLOGICALLY RESEMBLING BURKITT'S TUMOR.

Authors:  R F DORFMAN
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells.

Authors:  F Mitelman; M Andersson-Anvret; L Brandt; D Catovsky; G Klein; G Manolov; Y Manolova; E Mark-Vendel; P G Nilsson
Journal:  Int J Cancer       Date:  1979-07-15       Impact factor: 7.396

3.  Antigen-binding mutants of mouse myeloma cells.

Authors:  W D Cook; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  t(8;14) translocation in a Burkitt's type of lymphoblastic leukaemia (L3).

Authors:  R Berger; A Bernheim; J C Brouet; M T Daniel; G Flandrin
Journal:  Br J Haematol       Date:  1979-09       Impact factor: 6.998

5.  Surgace IgM specificity on cells derived from a Burkitt's lymphoma.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

6.  Immunoglobulin determinants on the surface of mouse lymphoid cells.

Authors:  M C Raff; M Sternberg; R B Taylor
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

7.  Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia.

Authors:  I T Magrath; J L Ziegler
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

8.  Acute leukemia with Burkitt's tumor cells: A study of six cases with special reference to lymphocyte surface markers.

Authors:  G Flandrin; J C Brouet; M T Daniel; J L Preud'homme
Journal:  Blood       Date:  1975-02       Impact factor: 22.113

9.  Evolutionary nucleotide replacements in DNA.

Authors:  T H Jukes; J L King
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

10.  Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers.

Authors:  R B Mann; E S Jaffe; R C Braylan; K Nanba; M M Frank; J L Ziegler; C W Berard
Journal:  N Engl J Med       Date:  1976-09-23       Impact factor: 91.245

View more
  18 in total

Review 1.  Burkitt's lymphoma: new insights into molecular pathogenesis.

Authors:  C Bellan; S Lazzi; G De Falco; A Nyongo; A Giordano; L Leoncini
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

2.  Clonal evolution of B cells in transformation from low- to high-grade lymphoma.

Authors:  A Matolcsy; E J Schattner; D M Knowles; P Casali
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

Authors:  C Cinti; L Leoncini; A Nyongo; F Ferrari; S Lazzi; C Bellan; R Vatti; A Zamparelli; G Cevenini; G M Tosi; P P Claudio; N M Maraldi; P Tosi; A Giordano
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil.

Authors:  Iguaracyra Araujo; Achiléa Lisboa Bittencourt; Helenemarie S Barbosa; Eduardo Martins Netto; Núbia Mendonça; Hans-Dieter Foss; Michael Hummel; Harald Stein
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

Review 5.  Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells.

Authors:  H K Müller-Hermelink; A Greiner
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

6.  Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease.

Authors:  T Goossens; U Klein; R Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.

Authors:  D Lenze; L Leoncini; M Hummel; S Volinia; C G Liu; T Amato; G De Falco; J Githanga; H Horn; J Nyagol; G Ott; J Palatini; M Pfreundschuh; E Rogena; A Rosenwald; R Siebert; C M Croce; H Stein
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

8.  High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis.

Authors:  Katharine A Lombardo; David G Coffey; Alicia J Morales; Christopher S Carlson; Andrea M H Towlerton; Sarah E Gerdts; Francis K Nkrumah; Janet Neequaye; Robert J Biggar; Jackson Orem; Corey Casper; Sam M Mbulaiteye; Kishor G Bhatia; Edus H Warren
Journal:  Blood Adv       Date:  2017-03-21

9.  Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells.

Authors:  Jie Zheng; Jing Huang; Yuntao Mao; Shiqing Liu; Xin Sun; Xiaohui Zhu; Teng Ma; Li Zhang; Jiafu Ji; Youhui Zhang; C Cameron Yin; Xiaoyan Qiu
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

10.  Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach.

Authors:  Anke van Rijk; David Mason; Margaret Jones; José Cabeçadas; Mateus Crespo; Juan Cruz Cigudosa; Juan Fernando Garcia; Lorenzo Leoncini; Mario Cocco; Martin-Leo Hansmann; Anja Mottok; Christiane Copie Bergman; Maryse Baia; Dimitra Anagnostou; Evi Pouliou; Stephen Hamilton Dutoit; Mette Hjøllund Christiansen; Tim Svenstrup Poulsen; Steen Hauge Matthiesen; Jacques van Dongen; J Han van Krieken
Journal:  J Hematop       Date:  2008-08-29       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.